Acadian Asset Management LLC Coherus Bio Sciences, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.59 - $3.85 $941,648 - $2.28 Million	592,232 New	592,232 $1.97 Million
Q2 2022 Aug 09, 2022	BUY	$5.86 - $13.23 $33,519 - $75,675	5,720 New	5,720 $41,000
Q3 2020 Nov 09, 2020	SELL	$17.41 - $19.89 $1.52 Million - $1.74 Million	-87,391 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$14.43 - $19.16 $1.54 Million - $2.05 Million	-107,066 Reduced 55.06%	87,391 $1.56 Million
Q1 2020 May 11, 2020	BUY	$11.67 - $22.53 $2.27 Million - $4.38 Million	194,457 New	194,457 $3.15 Million

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $81.6M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.